缺血性脑卒中与血管性痴呆在发病机制上的联系

师千与; 程全成; 陈春花

doi:10.16098/j.issn.0529-1356.2021.05.025

PDF(1327 KB)

解剖学报 ›› 2021, Vol. 52 ›› Issue (5) : 834-838. DOI: 10.16098/j.issn.0529-1356.2021.05.025

综述

缺血性脑卒中与血管性痴呆在发病机制上的联系

师千与¹ 程全成² 陈春花^2*

作者信息 +

Relationship of pathogenesis between ischemic stroke and vascular dementia

SHI Qian-yu¹ CHENG Quan-cheng² CHEN Chun-hua^2*

Author information +

文章历史 +

摘要

缺血性脑卒中造成的脑损伤可以继发认知或行为障碍。研究表明，缺血性脑卒中是血管性痴呆的一个危险因素。涉及共同的病理生理过程及相似的危险因素。在发病机制上存在联系，均包含了内皮细胞功能紊乱及血脑屏障通透性增高。缺血性脑卒中后存在的微梗死、微血管改变、局部神经元萎缩和神经退行性变均可能是继发血管性痴呆的病理机制。但是，两者相关的具体机制仍然未完全阐明。

Abstract

Ischemic stroke could cause brain damage and subsequent cognitive or behavioral disorders. Studies have shown that ischemic stroke is a risk factor of vascular dementia, involving common pathophysiological processes and similar risk factors, which are related in pathogenesis, including endothelial dysfunction and the disrupted blood-brain barrier permeability. Micro infarct, microvascular changes, brain atrophy and neurodegenerative changes may be the pathological mechanism of secondary vascular dementia. However, the specific mechanism of the two is still not fully clarified, which will become the focus of future research.

导出引用

师千与程全成陈春花. 缺血性脑卒中与血管性痴呆在发病机制上的联系[J]. 解剖学报. 2021, 52(5): 834-838 https://doi.org/10.16098/j.issn.0529-1356.2021.05.025

SHI Qian-yu CHENG Quan-cheng CHEN Chun-hua. Relationship of pathogenesis between ischemic stroke and vascular dementia[J]. Acta Anatomica Sinica. 2021, 52(5): 834-838 https://doi.org/10.16098/j.issn.0529-1356.2021.05.025

中图分类号： R322.81

参考文献

［1］ Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013［J］. Lancet, 2015, 386(9995):743-800.

［2］ Hankey, GJ. Stroke［J］. Lancet, 2017, 389(10069):641-654.

［3］ Zhang HCh, Jing KJ, Li XF, et al. Research progress on primary prevention of stroke［J］. Chinese Nursing Research, 2019, 33(22):3889-3892.（in Chinese）

张红池, 井坤娟, 李雪霏, 等. 脑卒中一级预防研究进展［J］. 护理研究，2019，33(22)：3889-3892.

［4］ Jiang B. Enlightenment and suggestion on the general medical service from the current epidemic characteristics and prevention status of stroke in China［J］. Chinese General Practice, 2019, 22(30):3653-3661.（in Chinese）

江滨. 现阶段我国脑卒中流行特征及防治现状对全科医疗服务的启示和建议［J］. 中国全科医学，2019，22(30)：3653-3661.

［5］ Vijayan M, Reddy PH. Stroke, vascular dementia, and Alzheimer’s disease: molecular links［J］. J Alzheimers Dis, 2016, 54(2):427-443.

［6］ Gao LW, Sun Q, Huang XX, et al. Mitochondrial dysfunction in vascular dementia［J］. Journal of Brain and Nervous Diseases, 2020, 28(2):121-124.（in Chinese）

高立伟, 孙强, 黄小茜, 等. 血管性痴呆中的线粒体功能障碍［J］. 脑与神经疾病杂志，2020，28(2)：121-124.

［7］ Liu W, Hu P, Feng B. Research progress of rat model of vascular dementia［J］. Acta Laboratorium Animalis Scientia Sinica, 2019, 27(6):805-809.（in Chinese）

刘伟, 胡鹏, 冯波. 血管性痴呆大鼠模型的研究进展［J］. 中国实验动物学报，2019，27(6)：805-809.

［8］ Pang ZhY. Research progress on risk factors and pathogenesis of vascular dementia［J］. Jilin Medical Journal, 2019, 40(12):2890-2892.（in Chinese）

庞振阳. 血管性痴呆的危险因素及发病机制的研究进展［J］. 吉林医学，2019，40(12)：2890-2892.

［9］ Teng YH. Study on risk factors of ischemic stroke in youth and ischemic stroke in the elderly［J］. World Journal of Complex Medicine, 2019, 5(12):50-52.（in Chinese）

滕玉环. 青年缺血性脑卒中与老年缺血性脑卒中的危险因素研究［J］. 世界复合医学，2019，5(12)：50-52.

［10］ Zou L, Meng XW. Research progress of preventable risk factors for ischemic stroke［J］. Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease, 2019, 27(11):98-101.（in Chinese）

邹莉, 孟祥武. 缺血性脑卒中可预防性危险因素的研究进展［J］. 实用心脑肺血管病杂志，2019，27(11)：98-101.

［11］ Madden, JA. Role of the vascular endothelium and plaque in acute ischemic stroke［J］. Neurology, 2012, 79(13 Suppl 1):S58-62.

［12］ Keep, RF, Xiang J, Ennis SR, et al. Blood-brain barrier function in intracerebral hemorrhage ［J］. Acta Neurochir Suppl, 2008, 105:73-77.

［13］ Prakash R, Carmichael ST. Blood-brain barrier breakdown and neovascularization processes after stroke and traumatic brain injury［J］. Curr Opin Neurol, 2015, 28(6):556-564.

［14］ Liu J, Jin X, Liu KJ, et al. Matrix metalloproteinase-2-mediated occludin degradation and caveolin-1-mediated claudin-5 redistribution contribute to blood-brain barrier damage in early ischemic stroke stage［J］. J Neurosci, 2012, 32(9):3044-3057.

［15］ Qi Z, Liang J, Pan R, et al. Zinc contributes to acute cerebral ischemia-induced bloodbrain barrier disruption［J］. Neurobiol Dis, 2016, 95:12-21.

［16］ Reuter B, Rodemer C, Grudzenski S, et al. Effect of simvastatin on MMPs and TIMPs in human brain endothelial cells and experimental stroke［J］. Transl Stroke Res, 2015, 6(2):156-159.

［17］ Yang Y, Rosenberg GA. Blood-brain barrier breakdown in acute and chronic cerebrovascular disease［J］. Stroke, 2011, 42(11):3323-3328.

［18］ Gelderblom M, Leypoldt F, Steinbach K, et al. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke［J］. Stroke, 2009, 40(5):1849-1857.

［19］ De Meyer SF, Denorme F, Langhauser F, et al. Thromboinflammation in stroke brain damage［J］. Stroke, 2016, 47(4):1165-1172.

［20］ Iadecola C, Anrather J. The immunology of stroke: from mechanisms to translation［J］. Nat Med, 2011, 17(7):796-808.

［21］ Yin MF, Yang LY. Pathogenesis and prevention management of stroke［J］. Advances in Clinical Medicine, 2019, 9(11):1243-1246.（in Chinese）

尹美方, 杨乐怡. 脑卒中的发病机制及预防管理［J］. 临床医学进展，2019，9(11)：1243-1246.

［22］ Anrather J, Iadecola C. Inflammation and stroke: an overview［J］. Neurotherapeutics, 2016, 13(4):661-670.

［23］ Rezaie AR. Protease-activated receptor signalling by coagulation proteases in endothelial cells［J］. Thromb Haemost, 2014, 112(5):876-882.

［24］ Osthoff M, Katan M, Fluri F, et al. Mannosebinding lectin deficiency is associated with smaller infarction size and favorable outcome in ischemic stroke patients［J］. PLoS One, 2011, 6(6): e21338.

［25］ Chamorro A, Dirnagl U, Urra X, et al. Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation［J］. Lancet Neurol, 2016, 15(8):869-881.

［26］ Petrovic-Djergovic D, Goonewardena SN, Pinsky DJ. Inflammatory disequilibrium in stroke［J］. Circ Res, 2016, 119(1):142-158.

［27］ Benakis C, Garcia-Bonilla L, Iadecola C, et al. The role of microglia and myeloid immune cells in acute cerebral ischemia［J］. Front Cell Neurosci, 2015, 8:461.

［28］ Singh V, Roth S, Veltkamp R, et al. HMGB1 as a key mediator of immune mechanisms in ischemic stroke［J］. Antioxid Redox Signal, 2016, 24(12):635-651.

［29］ Sweeney MD, Montagne A, Sagare AP, et al. Vascular dysfunction-the disregarded partner of Alzheimer’s disease［J］. Alzheimers Dement, 2019, 15(1):158-167.

［30］ Alzheimer’s Association Calcium Hypothesis Workgrou. Calcium hypothesis of Alzheimer’s disease and brain aging: a framework for integrating new evidence into a comprehensive theory of pathogenesis［J］. Alzheimers Dement, 2017, 13(2):178-182.

［31］ Jellinger KA. Pathology and pathogenesis of vascular cognitive impairment-a critical update［J］. Panminerva Med, 2004,46(4):217-226.

［32］ Shu Y, Zhang H, Kang T, et al. PI3K/Akt signal pathway involved in the cognitive impairment caused by chronic cerebral hypoperfusion in rats［J］. PLoS One, 2013, 8(12): e81901.

［33］ Vijayan M, Kumar S, Bhatti JS, et al. Molecular links and biomarkers of stroke, vascular dementia, and Alzheimer’s disease［J］. Prog Mol Biol Transl Sci, 2017,146:95-126.

［34］ Thal DR, Grinberg LT, Attems J. Vascular dementia: different forms of vessel disorders contribute to the development of dementia in the elderly brain［J］. Exp Gerontol, 2012, 47(11):816-824.

［35］ Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia a statement for healthcare professionals from the american heart association/american stroke association［J］. Stroke, 2011, 42(9):2672-2713.